Trials / Conditions / Proliferative Diabetic Retinopathy (PDR)
Proliferative Diabetic Retinopathy (PDR)
6 registered clinical trials studyying Proliferative Diabetic Retinopathy (PDR) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | High Dose Eylea for Proliferative Diabetic Retinopathy Outcomes NCT07118670 | Edward Wood, MD | Phase 4 |
| Recruiting | Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR NCT06790784 | Jaeb Center for Health Research | Phase 3 |
| Terminated | A Study Assessing Efficacy and Safety of OC-10X in the Treatment of PDR NCT02735369 | OcuCure Therapeutics, Inc. | Phase 2 |
| Completed | Phase I Study Assessing the Ocular and Systemic Safety and Tolerability of OC-10X NCT01869933 | OcuCure Therapeutics, Inc. | Phase 1 |
| Completed | Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination Wi NCT01594281 | Novartis Pharmaceuticals | Phase 2 |
| Completed | Comparison of Changes of Inflammatory Proteins in Aqueous Humour of Subjects Treated With Avastin vs Lucentis NCT01760746 | University of British Columbia | — |